Petros pharmaceuticals announces closing of $10 million offering

New york, dec. 2, 2021 /prnewswire/ -- petros pharmaceuticals, inc. (nasdaq: ptpi), a leading provider of therapeutics for men's health, today announced the closing of its previously announced registered direct offering and private placement with the company's largest investor and other existing investors for gross proceeds of approximately 10.0 million. petros pharmaceuticals intends to use the net proceeds from this offering for expansion of its men's health platform and for working capital and general corporate purposes.
PTPI Ratings Summary
PTPI Quant Ranking